Published in Vaccine Weekly, February 22nd, 2006
According to a study from Slovenia, "Understanding of immunological processes at the molecular level in the cancer-bearing organism is the prerequisite for development of specific tumor vaccines. Most of these vaccines are aimed at enhancing the immunogenicity of the antigens presented by the tumor cells. Since dendritic cells (DC) are potent antigen-presenting cells (APC) in the organism, they are considered as a powerful tool to deliver the signals essential for the activation of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.